查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1776695

2032 年女性科技市場預測：按類型、功能、應用、最終用戶和地區進行的全球分析

FemTech Market Forecasts to 2032 - Global Analysis By Type, Functional Capability, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，全球女性科技市場預計在 2025 年達到 480.5 億美元，到 2032 年將達到 1,564.8 億美元，預測期內的複合年成長率為 18.37%。

Femtech 是「女性科技」的縮寫，指的是一系列旨在促進女性健康和福祉的產品、服務、診斷和軟體。該行業提供各種各樣的解決方案，包括用於追蹤月經的應用程式、用於管理更年期的工具、生育和妊娠監測設備，以及為患有慢性疾病、心理健康問題和性健康問題的人提供支援的線上資源。此外，由於人們對性別特定醫療保健需求的認知不斷提高，女性科技正在幫助縮小醫療保健領域的性別數據差距，並增強女性的個人化照護。

根據世界經濟論壇的數據，光是九種疾病就佔了女性數據和照護健康差距的三分之一，但從 2019 年到 2023 年，它們獲得的累積研究資金不到 1%。縮小這些差距可以在 2040 年前每年節省 2700 萬個殘疾調整生命年，並產生 1 兆美元的全球 GDP。

提升婦女健康知識

近期，全球發生了一場文化變革，一些過去被污名化或忽視的女性健康問題，例如月經、更年期、不孕症問題和生育權利，如今正被公開討論並優先考慮。現今的女性更積極主動監測月經週期、管理經前症候群 (PMS) 症狀、儘早解決不孕症問題，並尋求針對卵巢症候群 (PCOS) 和子宮內膜異位症等長期疾病的專門治療。此外，女性健康組織、社群媒體影響力人士和教育宣傳活動是提升女性意識的關鍵驅動力。因此，對能夠提供診斷、資訊和支援的女性科技解決方案的需求日益成長。

標準和法規不明確

缺乏法律規範是女性科技產業面臨的最大問題之一，尤其是在穿戴式感測器、行動應用程式和基於人工智慧的診斷等數位健康產品方面。許多國家對於特定女性科技產品究竟屬於健康工具或醫療設備存在不確定性，這會影響產品分類、核准流程和合規標準。這項監管灰色地帶可能會阻礙創新、限制市場進入並阻礙投資，尤其對於那些缺乏資源來應對複雜法律環境的新興企業而言。此外，由於各國標準不一，導致成長分散，全球企業發展也面臨挑戰。

探索更年期與中年健康

中老年女性一直以來都未被充分重視，如今她們正成為女性科技產業的關鍵消費族群。每年有數百萬女性進入更年期和閉經，這增加了她們對潮熱、失眠、荷爾蒙失衡和心理問題等症狀的解決方案的需求。這群人通常願意為改善壽命和生活品質的健康和保健服務付費。此外，開發荷爾蒙補充療法或人工智慧驅動的症狀追蹤平台等專業產品的女性科技企業可以擴大規模，並吸引那些通常富有的忠實客戶。

網路安全與資料外洩風險

中老年女性一直以來都未被充分重視，如今她們正成為女性科技產業的關鍵消費族群。每年有數百萬女性進入更年期和閉經，這增加了她們對潮熱、失眠、荷爾蒙失衡和心理問題等症狀的解決方案的需求。這群人通常願意為改善壽命和生活品質的健康和保健服務付費。此外，開發荷爾蒙補充療法平台和人工智慧輔助症狀追蹤等專業產品的女性科技企業可以接觸到這個不斷擴大、積極參與且通常富裕的客戶群。

COVID-19的影響：

新冠疫情對女性科技市場產生了雙重影響，既加速了成長，也帶來了挑戰。一方面，一些女性科技產品（尤其是基於硬體的解決方案）的初期應用受到了供應鏈中斷、臨床試驗延遲以及面對面醫療服務受限等因素的阻礙。另一方面，遠端醫療、經期追蹤應用、生育監測工具以及女性專屬心理健康平台的使用率均因疫情而有所成長，顯著加速了數位化醫療的發展趨勢。由於傳統醫療服務因社交隔離措施而關閉和受限，女性轉向數位化解決方案來管理她們的情緒、生殖和懷孕健康。因此，女性科技領域的投資和用戶參與度激增。

預計在預測期內，監控和追蹤部分將成長至最大的部分。

預計監測和追蹤領域將在預測期內佔據最大的市場佔有率。此類別包括穿戴式科技、數位平台和行動應用程式，使女性能夠監測排卵、月經週期、生育能力、懷孕情況、更年期症狀和一般健康指標。女性科技的主導地位源自於對預防性和個人化照護日益成長的需求、人們對女性健康議題的認知不斷提高，以及穿戴式裝置和智慧型手機的普及率不斷提高。此外，女性科技產業高度依賴監測和追蹤，因為這些工具使女性能夠掌控自己的健康狀況，及早發現異常，並在無需持續臨床干預的情況下做出明智的決策。

預計預測期內懷孕和護理部門的複合年成長率最高。

預計孕產婦護理領域將在預測期內實現最高成長率。隨著孕產婦健康意識的不斷提高，以及穿戴式胎兒分娩監視器、數位懷孕追蹤應用程式、遠距醫療平台和產後護理解決方案的日益普及，該行業的爆炸式成長正在加速。越來越多的女性開始使用科技工具來即時了解胎兒發育、營養、運動、心理健康和母乳哺育支持等資訊。職業母親人數的增加、遠端醫療服務覆蓋率的擴大以及部分地區生育率的上升，都推動了該領域的需求成長。這些因素共同支撐了該領域強勁的年複合成長率，並使其在女性科技發展方向中發揮關鍵作用。

比最大的地區

由於人們對女性健康問題的強烈關注、高智慧型手機普及率以及先進的數位基礎設施，預計北美將在預測期內佔據最大的市場佔有率。美國憑藉其蓬勃發展的女性科技Start-Ups生態系統、強大的資金籌措以及支持數位健康創新的創業投資框架，在該地區其他國家中脫穎而出。不斷上漲的醫療成本和自我管理預防保健的趨勢，導致對更年期管理工具、生育護理解決方案和生育追蹤應用程式的需求不斷成長。此外，保險公司和職場健康舉措擴大提供女性科技產品，進一步鞏固了該地區的市場主導地位。

複合年成長率最高的地區：

在預測期內，亞太地區預計將實現最高的複合年成長率，這得益於數位醫療基礎設施投資的增加、網際網路和智慧型手機普及率的提高以及女性健康意識的不斷增強。在中國、印度、日本和韓國等國家，尤其是在都市區和精通科技的人群中，行動醫療應用程式、生育治療解決方案和孕產婦護理平台的需求旺盛。該地區的快速成長也得益於政府為改善女性獲得醫療保健的機會所採取的舉措，以及該地區女性科技新興企業的崛起。隨著醫療保健產業的快速數位化，亞太地區正成為全球女性科技產業的關鍵成長引擎。

免費客製化服務

訂閱此報告的客戶可享有以下免費自訂選項之一：

  • 公司簡介
    • 對其他市場公司（最多 3 家公司）進行全面分析
    • 主要企業的SWOT分析（最多3家公司）
  • 區域細分
    • 根據客戶興趣對主要國家市場進行估計、預測和複合年成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 研究範圍
  • 調查方法
    • 資料探勘
    • 數據分析
    • 數據檢驗
    • 研究途徑
  • 研究材料
    • 主要研究資料
    • 次級研究資訊來源
    • 先決條件

第3章市場走勢分析

  • 驅動程式
  • 抑制因素
  • 機會
  • 威脅
  • 應用分析
  • 最終用戶分析
  • 新興市場
  • COVID-19的影響

第4章 波特五力分析

  • 供應商的議價能力
  • 買家的議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭對手之間的競爭

第5章 全球女性科技市場（按類型）

  • 裝置
    • 穿戴式裝置
    • 診斷設備
  • 軟體
    • 月經健康應用
    • 生育治療/輔助生殖技術應用程式
    • 懷孕和產後護理應用程式
    • 更年期管理應用程式
    • 通用女性健康與保健應用程式
  • 服務
    • 遠端醫療和虛擬護理
    • 諮詢和支援服務
    • 基於訂閱的健康服務
    • 平台化服務

第6章 全球女性科技市場（按功能）

  • 診斷
  • 監控和追蹤
  • 治療/干預
  • 健康教育和意識
  • 諮詢/遠端醫療

第7章 全球女性科技市場（按應用）

  • 懷孕和哺乳
  • 生殖健康與避孕
  • 月經健康
  • 一般健康
  • 骨盆腔和子宮健康
  • 性健康和保健
  • 更年期護理
  • 心理和情緒健康
  • 腫瘤學
  • 其他用途

第8章 全球女性科技市場（依最終用戶）

  • 直接面對消費者
  • 醫院
  • 手術中心
  • 不孕不育診所
  • 診斷中心
  • 其他最終用戶

9. 全球女性科技市場（按地區）

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲地區

第10章 重大進展

  • 協議、夥伴關係、合作和合資企業
  • 收購與合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第11章 公司概況

  • Google, Inc
  • Apple, Inc
  • Sirona Hygiene Private Limited
  • Glow, Inc
  • BioWink GmbH
  • Natural Cycles USA Corp
  • Athena Feminine Technologies
  • Flo Health, Inc.
  • HeraMed
  • iSono Health, Inc.
  • Chiaro Technology Limited
  • Joylux, Inc.
  • Nuvo Inc.
  • FemTec Health Inc
  • Simple Health Inc
Product Code: SMRC30026

According to Stratistics MRC, the Global FemTech Market is accounted for $48.05 billion in 2025 and is expected to reach $156.48 billion by 2032 growing at a CAGR of 18.37% during the forecast period. FemTech, short for "female technology," is a term used to describe an expanding range of products, services, diagnostics, and software aimed at promoting the health and well-being of women. This industry offers a broad range of solutions, such as apps for tracking menstruation, tools for managing menopause, fertility and pregnancy monitoring devices, and online resources for supporting people with chronic illnesses, mental health issues, and sexual health. Moreover, FemTech is helping to bridge the gender data gap in medicine and enhance women's individualized care as a result of growing awareness of gender-specific healthcare needs.

According to the World Economic Forum, only nine conditions account for one-third of women's health gaps in data and care-but together these received less than 1% of cumulative research funding between 2019 and 2023. Closing these gaps could unlock 27 million DALYs each year and generate $1 trillion in global GDP by 2040.

Market Dynamics:

Driver:

Growing knowledge of women's health concerns

A global cultural shift has occurred recently toward the open discussion and prioritization of women's health issues that were previously stigmatized or disregarded, including menstruation, menopause, fertility issues, and reproductive rights. Today's women are more proactive in monitoring their cycles, controlling the symptoms of PMS, addressing infertility early, and seeking professional treatment for long-term conditions like polycystic ovary syndrome (PCOS) and endometriosis. Additionally, women's health organizations, social media influencers, and education campaigns are the main drivers of this rising awareness. Consequently, there is now a greater need for FemTech solutions that provide diagnosis, information, and support.

Restraint:

Absence of standards and regulatory clarity

The lack of precise and uniform regulatory frameworks is one of the biggest issues facing the FemTech sector, particularly with regard to digital health products like wearable sensors, mobile apps, and AI-based diagnostics. There is uncertainty in many nations regarding whether specific FemTech products are considered wellness tools or medical devices, which has an impact on product classification, approval processes, and compliance standards. Especially for startups that lack the resources to handle complicated legal environments, this regulatory gray area can impede innovation, limit market access, and deter investment. Furthermore, global expansion is challenging due to disparate national standards, which results in fragmented growth.

Opportunity:

Expansion into menopause and midlife health

Midlife and older women, who have historically been underrepresented, are becoming a significant consumer segment in the FemTech industry. Every year, millions of women go through perimenopause and menopause, increasing the need for ways to deal with symptoms like hot flashes, insomnia, hormone imbalance, and mental health issues. For health and wellness services that improve longevity and quality of life, this group is frequently willing to pay. Additionally, FemTech businesses that create specialized products, such as platforms for hormone replacement therapy or AI-driven symptom tracking, can reach this expanding, devoted, and frequently wealthy clientele.

Threat:

Risks to cybersecurity and data breach

Midlife and older women, who have historically been underrepresented, are becoming a significant consumer segment in the FemTech industry. Every year, millions of women go through perimenopause and menopause, increasing the need for ways to deal with symptoms like hot flashes, insomnia, hormone imbalance, and mental health issues. For health and wellness services that improve longevity and quality of life, this group is frequently willing to pay. Additionally, FemTech businesses that create specialized products, such as platforms for hormone replacement therapy or AI-driven symptom tracking, can reach this expanding, devoted, and frequently wealthy clientele.

Covid-19 Impact:

On the FemTech market, the COVID-19 pandemic had a dual effect, serving as a growth accelerator and a challenge. From one perspective, the initial adoption of some FemTech products, particularly hardware-based solutions, was hampered by supply chain disruptions, postponed clinical trials, and limited access to in-person healthcare services. However, telemedicine, period tracking apps, fertility monitoring tools, and women-specific mental health platforms were all used more frequently as a result of the pandemic, which also greatly accelerated the trend toward digital health. As traditional care was restricted by lockdowns and social distancing, women resorted to digital solutions for managing their emotional, reproductive, and pregnancy health. This resulted in a spike in FemTech investment and user engagement.

The monitoring & tracking segment is expected to be the largest during the forecast period

The monitoring & tracking segment is expected to account for the largest market share during the forecast period. This category comprises wearable technology, digital platforms, and mobile apps that let women monitor their ovulation, menstrual cycles, fertility, pregnancy, menopause symptoms, and general health indicators. Its dominance stems from the growing demand for preventive and personalized care, the growing awareness of women's health issues, and the growing adoption of wearables and smartphones. Moreover, the FemTech industry relies heavily on monitoring & tracking because these tools enable women to take charge of their health, identify abnormalities early, and make educated decisions without continual clinical intervention.

The pregnancy and nursing care segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the pregnancy and nursing care segment is predicted to witness the highest growth rate. Rising maternal health awareness and the growing use of wearable fetal monitors, digital pregnancy tracking apps, remote consultation platforms, and postpartum care solutions are all contributing factors to this industry's explosive growth. For real-time insights into fetal development, nutrition, exercise, mental health, and breastfeeding support, women are increasingly using tech-enabled tools. Growing numbers of working mothers, increased telehealth access, and rising fertility rates in some areas all contribute to the demand. Additionally, these elements support the segment's robust compound annual growth rate and pivotal role in determining the direction of FemTech.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, driven by a strong awareness of women's health issues, a high smartphone penetration rate, and sophisticated digital infrastructure. With a thriving FemTech startup ecosystem, significant venture capital funding, and supportive regulations for digital health innovations, the U.S. stands out among the other countries in the region. Rising healthcare costs and the trend toward self-managed, preventive care are contributing factors to the growing demand for menopause management tools, pregnancy care solutions, and fertility tracking apps. Moreover, FemTech products are also increasingly being offered by insurance companies and workplace wellness initiatives, which further solidify the region's leading position in the market.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, driven by an increase in investment in digital healthcare infrastructure, a rise in internet and smartphone penetration, and a growing awareness of women's health. Mobile health apps, fertility solutions, and maternal care platforms are in high demand in countries like China, India, Japan, and South Korea, particularly among urban and tech-savvy populations. The region's rapid growth is also attributed to government initiatives to improve women's access to healthcare and the growing number of local FemTech startups. With the rapid digitization of healthcare, Asia-Pacific is becoming a major growth engine for the global FemTech sector.

Key players in the market

Some of the key players in FemTech Market include Google, Inc, Apple, Inc, Sirona Hygiene Private Limited, Glow, Inc, BioWink GmbH, Natural Cycles USA Corp, Athena Feminine Technologies, Flo Health, Inc., HeraMed, iSono Health, Inc., Chiaro Technology Limited, Joylux, Inc., Nuvo Inc., FemTec Health Inc and Simple Health Inc.

Key Developments:

In March 2025, Google LLC announced it has signed a definitive agreement to acquire Wiz, Inc., a leading cloud security platform headquartered in New York, for $32 billion, subject to closing adjustments, in an all-cash transaction. Once closed, Wiz will join Google Cloud. This acquisition represents an investment by Google Cloud to accelerate two large and growing trends in the AI era: improved cloud security and the ability to use multiple clouds.

In February 2025, Apple Inc. and Indonesia have agreed on terms to lift the country's ban on iPhone 16s, said people familiar with the matter, paving the way to end a five-month tug-of-war that forced the US tech giant to raise its promised investment in the country to $1 billion. The Ministry for Industry, which is responsible for upholding the ban, is set to sign a memorandum of agreement with Apple as soon as this week, according to people familiar with the talks, who asked not to be identified discussing private matters.

In October 2024, Flo Health has partnered with FemTech India to introduce its Pass It On Project via a special Diwali campaign. With a global base of over 80 million and 1.5 million monthly active users in India alone, Flo Health, a leading global period and ovulation tracker, is doubling down on its presence in the country. The Pass It on Project offers free Flo Premium subscriptions to women in 22 countries, where access to safe and credible health information is limited.

Types Covered:

  • Device
  • Software
  • Service

Functional Capabilities Covered:

  • Diagnostics
  • Monitoring & Tracking
  • Therapeutic/Intervention
  • Health Education & Awareness
  • Consultation/Telemedicine

Applications Covered:

  • Pregnancy and Nursing Care
  • Reproductive Health & Contraception
  • Menstrual Health
  • General Wellness
  • Pelvic & Uterine Health
  • Sexual Health & Wellness
  • Menopause Care
  • Mental Health & Emotional Wellbeing
  • Oncology
  • Other Applications

End Users Covered:

  • Direct to Consumer
  • Hospitals
  • Surgical Centers
  • Fertility Clinics
  • Diagnostic Centers
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global FemTech Market, By Type

  • 5.1 Introduction
  • 5.2 Device
    • 5.2.1 Wearable Devices
    • 5.2.2 Diagnostic Devices
  • 5.3 Software
    • 5.3.1 Menstrual Health Apps
    • 5.3.2 Fertility Management/Assisted Reproductive Technology Apps
    • 5.3.3 Pregnancy & Postpartum Care Apps
    • 5.3.4 Menopause Management Apps
    • 5.3.5 General Women's Health & Wellness Apps
  • 5.4 Service
    • 5.4.1 Telehealth & Virtual Care
    • 5.4.2 Counseling & Support Services
    • 5.4.3 Subscription Health Services
    • 5.4.4 Platform-based Services

6 Global FemTech Market, By Functional Capability

  • 6.1 Introduction
  • 6.2 Diagnostics
  • 6.3 Monitoring & Tracking
  • 6.4 Therapeutic/Intervention
  • 6.5 Health Education & Awareness
  • 6.6 Consultation/Telemedicine

7 Global FemTech Market, By Application

  • 7.1 Introduction
  • 7.2 Pregnancy and Nursing Care
  • 7.3 Reproductive Health & Contraception
  • 7.4 Menstrual Health
  • 7.5 General Wellness
  • 7.6 Pelvic & Uterine Health
  • 7.7 Sexual Health & Wellness
  • 7.8 Menopause Care
  • 7.9 Mental Health & Emotional Wellbeing
  • 7.10 Oncology
  • 7.11 Other Applications

8 Global FemTech Market, By End User

  • 8.1 Introduction
  • 8.2 Direct to Consumer
  • 8.3 Hospitals
  • 8.4 Surgical Centers
  • 8.5 Fertility Clinics
  • 8.6 Diagnostic Centers
  • 8.7 Other End Users

9 Global FemTech Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Google, Inc
  • 11.2 Apple, Inc
  • 11.3 Sirona Hygiene Private Limited
  • 11.4 Glow, Inc
  • 11.5 BioWink GmbH
  • 11.6 Natural Cycles USA Corp
  • 11.7 Athena Feminine Technologies
  • 11.8 Flo Health, Inc.
  • 11.9 HeraMed
  • 11.10 iSono Health, Inc.
  • 11.11 Chiaro Technology Limited
  • 11.12 Joylux, Inc.
  • 11.13 Nuvo Inc.
  • 11.14 FemTec Health Inc
  • 11.15 Simple Health Inc

List of Tables

  • Table 1 Global FemTech Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global FemTech Market Outlook, By Type (2024-2032) ($MN)
  • Table 3 Global FemTech Market Outlook, By Device (2024-2032) ($MN)
  • Table 4 Global FemTech Market Outlook, By Wearable Devices (2024-2032) ($MN)
  • Table 5 Global FemTech Market Outlook, By Diagnostic Devices (2024-2032) ($MN)
  • Table 6 Global FemTech Market Outlook, By Software (2024-2032) ($MN)
  • Table 7 Global FemTech Market Outlook, By Menstrual Health Apps (2024-2032) ($MN)
  • Table 8 Global FemTech Market Outlook, By Fertility Management/Assisted Reproductive Technology Apps (2024-2032) ($MN)
  • Table 9 Global FemTech Market Outlook, By Pregnancy & Postpartum Care Apps (2024-2032) ($MN)
  • Table 10 Global FemTech Market Outlook, By Menopause Management Apps (2024-2032) ($MN)
  • Table 11 Global FemTech Market Outlook, By General Women's Health & Wellness Apps (2024-2032) ($MN)
  • Table 12 Global FemTech Market Outlook, By Service (2024-2032) ($MN)
  • Table 13 Global FemTech Market Outlook, By Telehealth & Virtual Care (2024-2032) ($MN)
  • Table 14 Global FemTech Market Outlook, By Counseling & Support Services (2024-2032) ($MN)
  • Table 15 Global FemTech Market Outlook, By Subscription Health Services (2024-2032) ($MN)
  • Table 16 Global FemTech Market Outlook, By Platform-based Services (2024-2032) ($MN)
  • Table 17 Global FemTech Market Outlook, By Functional Capability (2024-2032) ($MN)
  • Table 18 Global FemTech Market Outlook, By Diagnostics (2024-2032) ($MN)
  • Table 19 Global FemTech Market Outlook, By Monitoring & Tracking (2024-2032) ($MN)
  • Table 20 Global FemTech Market Outlook, By Therapeutic/Intervention (2024-2032) ($MN)
  • Table 21 Global FemTech Market Outlook, By Health Education & Awareness (2024-2032) ($MN)
  • Table 22 Global FemTech Market Outlook, By Consultation/Telemedicine (2024-2032) ($MN)
  • Table 23 Global FemTech Market Outlook, By Application (2024-2032) ($MN)
  • Table 24 Global FemTech Market Outlook, By Pregnancy and Nursing Care (2024-2032) ($MN)
  • Table 25 Global FemTech Market Outlook, By Reproductive Health & Contraception (2024-2032) ($MN)
  • Table 26 Global FemTech Market Outlook, By Menstrual Health (2024-2032) ($MN)
  • Table 27 Global FemTech Market Outlook, By General Wellness (2024-2032) ($MN)
  • Table 28 Global FemTech Market Outlook, By Pelvic & Uterine Health (2024-2032) ($MN)
  • Table 29 Global FemTech Market Outlook, By Sexual Health & Wellness (2024-2032) ($MN)
  • Table 30 Global FemTech Market Outlook, By Menopause Care (2024-2032) ($MN)
  • Table 31 Global FemTech Market Outlook, By Mental Health & Emotional Wellbeing (2024-2032) ($MN)
  • Table 32 Global FemTech Market Outlook, By Oncology (2024-2032) ($MN)
  • Table 33 Global FemTech Market Outlook, By Other Applications (2024-2032) ($MN)
  • Table 34 Global FemTech Market Outlook, By End User (2024-2032) ($MN)
  • Table 35 Global FemTech Market Outlook, By Direct to Consumer (2024-2032) ($MN)
  • Table 36 Global FemTech Market Outlook, By Hospitals (2024-2032) ($MN)
  • Table 37 Global FemTech Market Outlook, By Surgical Centers (2024-2032) ($MN)
  • Table 38 Global FemTech Market Outlook, By Fertility Clinics (2024-2032) ($MN)
  • Table 39 Global FemTech Market Outlook, By Diagnostic Centers (2024-2032) ($MN)
  • Table 40 Global FemTech Market Outlook, By Other End Users (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.